Latest News
Via Talk Markets · March 2, 2026
Investors frowned on one point in the latest earnings report.
Via The Motley Fool · March 2, 2026

The market is buzzing with rumors of companies interested in buying Paypal. We look into whether there's fire behind the smoke.
Via The Motley Fool · March 2, 2026
The max benefit is out of reach for most people, but these things aren't.
Via The Motley Fool · March 2, 2026
Via Talk Markets · March 2, 2026
Steve Eisman, investor, called it incredible' that Nvidia grew revenue 73% in a year, but stock closed down. Eisman says AI spending is Nvidia's tailwind and risk. Private credit funded software buyouts at high valuation.
Via Benzinga · March 2, 2026
American Airlines shares fell 4% on Monday, tracking broader travel stocks, which declined amid escalating conflict in the Middle East and rising crude prices.
Via Stocktwits · March 2, 2026

Turning Point stock fell 20% despite a Q4 earnings beat, as Zig-Zag sales declined and investors weighed investment in Modern Oral segment.
Via Benzinga · March 2, 2026

BlackSky Technology Inc (NYSE:BKSY) shares are soaring on Monday amid the escalating U.S.–Iran conflict, now entering its third day.
Via Benzinga · March 2, 2026
Via MarketBeat · March 2, 2026
These S&P500 stocks have an unusual volume in today's sessionchartmill.com
Via Chartmill · March 2, 2026
This stablecoin stock still has a bright future.
Via The Motley Fool · March 2, 2026
Planet Labs stock is in the right place, at the right time. (But is the price right?)
Via The Motley Fool · March 2, 2026
Amazon stock got only a modest boost from its deal with OpenAI, which was wiped away by a decline on Monday. Here's what to know.
Via Investor's Business Daily · March 2, 2026
These companies have excellent records of enriching investors.
Via The Motley Fool · March 2, 2026
The company announced that its board adopted a limited-duration shareholder rights plan following Constellation Software's substantial increase in its stake in the company.
Via Stocktwits · March 2, 2026
Several alt indices have seen their first positive MACD crossing in years, market observers noted, indicating an "alt season" cycle.
Via Stocktwits · March 2, 2026
Via Benzinga · March 2, 2026
Shares of Hims & Hers Health, Inc. (NASDAQ: HIMS) are rising Monday after Secretary of Health and Human Services Robert F. Kennedy Jr. said on the Joe Rogan podcast that several peptide compounds, a popular wellness treatment, would be added to an approval list.
Via Benzinga · March 2, 2026
Via Benzinga · March 2, 2026
Via Benzinga · March 2, 2026
Via Benzinga · March 2, 2026
Via Benzinga · March 2, 2026
Anthropic's AI platform experienced technical disruptions on Monday amid a politically charged week. Despite a ban, military ties remain.
Via Benzinga · March 2, 2026
Unusual volume stocks are being observed in Monday's session.chartmill.com
Via Chartmill · March 2, 2026
Via Benzinga · March 2, 2026
Raymond James downgraded AeroVironment to ‘Underperform’ from ‘Strong Buy’ and removed the firm's prior $348 price target, as per TheFly.
Via Stocktwits · March 2, 2026
Despite spot gold prices rising on Monday, mining stocks Newmont and Barrick were trading in the red.
Via Stocktwits · March 2, 2026
Why does the shortest month of the year sometimes feel like the longest?
Via The Motley Fool · March 2, 2026

This clinical-stage biotech develops therapies for rare muscle diseases using its proprietary FORCE platform and research-driven approach.
Via The Motley Fool · March 2, 2026
U.S. and Israeli strikes on Iran lift WTI crude and ConocoPhillips. Goldman Sachs analyst Mehta predicts 24% FCF CAGR.
Via Benzinga · March 2, 2026

This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.
Via The Motley Fool · March 2, 2026
